atenolol has been researched along with Myxedema in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Myxedema: A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A single oral dose of atenolol 100 mg was given to 7 hypothyroid patients (4 F, 3 M), before and after correction of hypothyroidism, mean delay 3." | 7.68 | Evolution of atenolol kinetics when hypothyroidism is corrected. ( Courtois, H; Fresel, J; Gancel, A; Levesque, H; Moore, N; Richard, MO, 1990) |
| "A single oral dose of atenolol 100 mg was given to 7 hypothyroid patients (4 F, 3 M), before and after correction of hypothyroidism, mean delay 3." | 3.68 | Evolution of atenolol kinetics when hypothyroidism is corrected. ( Courtois, H; Fresel, J; Gancel, A; Levesque, H; Moore, N; Richard, MO, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Levesque, H | 1 |
| Richard, MO | 1 |
| Fresel, J | 1 |
| Gancel, A | 1 |
| Moore, N | 1 |
| Courtois, H | 1 |
1 other study available for atenolol and Myxedema
| Article | Year |
|---|---|
Evolution of atenolol kinetics when hypothyroidism is corrected.
Topics: Adult; Aged; Aged, 80 and over; Atenolol; Biological Availability; Female; Half-Life; Humans; Hypoth | 1990 |